Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
The node of Ranvier in CNS pathology.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.
Current management of relapsing-remitting multiple sclerosis.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Masquerading optic neuritis.
Why this is not multiple sclerosis: a case based approach.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
Biomarker time out.
Sequential activation of microglia and astrocyte cytokine expression precedes increased iba-1 or GFAP immunoreactivity following systemic immune challenge.
The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
Monoclonal Antibodies for Multiple Sclerosis Treatment.
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
Increased HLA-E expression in white matter lesions in multiple sclerosis.
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.

Pages